Dr. Avrum I Froimson, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 26900 Cedar Rd, Suite 305 South, Beachwood, OH 44122 Phone: 216-839-3734 Fax: 216-839-3727 |
Reuben Gobezie, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25501 Chagrin Blvd Ste 200, Beachwood, OH 44122 Phone: 844-746-8537 Fax: 216-450-1810 |
Mrs. Kimberly Lynn Trutza, APRN Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 25501 Chagrin Blvd, Beachwood, OH 44122 Phone: 216-545-4800 |
Dr. Jinyoung Jeong, M.D.,PH.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 26300 Seville Dr Apt 111, Beachwood, OH 44122 Phone: 216-269-3488 |
William J Petersilge, MD Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Auburn Dr # 210, Beachwood, OH 44122 Phone: 216-844-5595 Fax: 216-844-5522 |
News Archive
The Senate Health, Education, Labor and Pensions Committee began amending their version of sweeping health overhaul legislation Thursday, days after a Congressional Budget Office report found the bill would cost $1 trillion over ten years, leaving 37 million people uninsured and Senate Republicans skeptical, the Associated Press reports.
Archus Orthopedics, Inc. has announced that the European Patent Office has confirmed the validity of its patent number EP-B-1223872 following an Opposition that concluded with oral proceedings on January 10, 2007 in Munich, Germany.
Mount Sinai researchers have developed a therapy that shows promise against a deadly pediatric leukemia. The small-molecule therapy was highly effective in fighting a type of acute myeloid leukemia in both in vitro and in vivo experiments, according to research published in Science Translational Medicine in September.
What will happen if the Western Pacific's health workforce, seeking better-paying jobs and professional advancement abroad, continue to migrate as the region's population ages, the burden of chronic disease rises and new health threats emerge?
The Norwegian pharmaceutical company Lytix Biopharma AS today announced approvals from the Norwegian Medicines Agency ("Statens legemiddelverk") and the Swedish Medical Products Agency ("Läkemedelverket") to commence Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.
› Verified 4 days ago